Cancer

Combination immunotherapy targets cancer resistance

Cancer immunotherapy drugs have had notable but limited success because in many cases, tumors develop resistance to treatment. But researchers at Yale and Stanford have identified an experimental antibody that overcomes this ...

13 hours ago
popularity12 comments 0